systematic review meta-analysis network meta-analysis

Select myocardial revascularizationcholesterol lowering interventionanticoagulantantithromboticsglucose lowering for cardiovascular preventionangiotensin-receptor blockersfibrinolysis all indication togetheruncoded clinical condition ***       atorvastatinfluvastatinlovastatinpravastatinrosuvastatinsimvastatincaptoprilramiprilirbesartanlosartantelmisartanvalsartancandesartanaleglitazarertugliflozinsemaglutidealogliptinapixabanardeparinaspirinbiolimus eluting stentbivalirudincanagliflozinCertoparinclopidogrelcoumadindabigatrandactinomycin eluting stentdalteparindapagliflozindrug-eluting stentsempagliflozinenoxaparineverolimus eluting stentexenatidefondaparinuxfraxiparinglarginelinagliptinliraglutidelixisenatide logiparinnadroparinolmesartanpaclitaxelpioglitazonereviparinrivaroxabanrt-PAsaxagliptinsirolimus eluting stentsitagliptinstreptokinasetinzaparintriflusalUFHurokinasewarfarinzotarolimus eluting stent      

Filter

Group by Group by... nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition MA  in first nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition  in second nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition  in third	Description Synopsis Comparison Treatments Patients Characteristics Method Risk of bias References None Tools Indexation					Results Global trial result Main results All results All result tag NCT results	All cause death (362)Major bleeding (162)myocardial infarction (fatal and non fatal) (134)stroke (fatal and non fatal) (116)Cardiovascular death (107)MACE (67)asymptomatic DVT (65)Bleeding (62)cardiovascular events (61)Coronary event (57)target lesion revascularisation (55)Symptomatic pulmonary embolism (54)non-fatal pulmonary embolism (53)Symptomatic venous thromboembolism (DVT, PE) (52)Stent thrombosis (any, end of follow up) (51)proximal DVT (51)total VTE and all-cause mortality (48)Deep vein thrombosis (47)wound haematoma / infection (42)Non fatal MI (39)major VTE (fatal and non fatal DVT,PE) (39)Recurrent thromboembolic event (38)thrombo-embolic event (cerebral or systemic) (37)distal DVT (36)Fatal stroke (35)angiographic restenosis (34)cardiac death (33)TE event or ischemic stroke or systemic embolism (33)Haemmorhagic stroke (30)Fatal bleeding (29)Symptomatic deep-vein thrombosis (29)Minor bleeding (27)major or clinically relevant non-major bleeding (27)ischemic stroke (25)transfusion (24)fatal pulmonary embolism (24)4y stent thrombosis (ARC) (23)Coronary death (23)systemic thrombo-embolic complication (23)late stent thrombosis (31days - 1year) (22)Revascularization (22)target-vessel revascularization (21)Adverse events (20)Fatal MI (20)macrovascular events (18)Non fatal stroke (17)myocardial infarction or death (17)Short term haemorrhage (17)non cardiovascular death (16)Coronary death and non fatal MI (15)recurrent angina (15)Heart failure (15)CABG (14)Rhabdomyolysis (14)hospitalisation for heart failure (14)symptomatic venous thromboembolism at the end of treatment (12)new-onset diabetes (11)sub acute stent thrombosis (1-30 days) (10)Death from cancer (10)cardiovascular events at 1 month (10)cardiovascular events at 4 months (10)Thrombus extension (10)Hospitalization for any reason (10)Myopathy (9)Hypotension (8)Diabetes onset (8)Acute stent thrombosis (<=24h) (7)Venous thromboembolism (7)Death from any cause or hospitalization for any reason (7)microvascular events (7)Cancer (6) (6)Cough (6)4 yr stent thrombosis (5)2 yr TLR (5)recurrence of pulmonary embolism (5)4 yr MI (4)4 yr TLR (4)death at 30 days (4)myocardial infarction at 30 days (4)Unplanned revascularisation for ischaemia (4)Hyperkalaemia (4)angiodema (4)macrovascular or microvascular events (4)in-lesion binary restenosis (3)2 yr MACE (3)4 yr mortality from all causes (3)4 yr death or MI (3)death, myocardial infarction, or recurrent at 30 days (3)death at 3 months (3)Long term death (3)Thrombocytopenia (3)death, MI, unplanned revascularization (3)any bleedings (3)nephropathy (3)2 yr Death (all cause) (2)Deaths or MI (2)atrial fibrillation (2)death, myocardial infarction, or recurrent at 14 days (2)All-cause hospitalisation (2)Sudden death (2)lung cancer (2)retinopathy (2)Amputations (2)PTCA (1)stroke or TIA (1)TIA (1)Non vascular death (1)Drop in platelet count of 50% (1)net benefit (1)reinfarction (1)In-hospital death (1)reinfarction at 30 days (1)death at 30 days (1)exacerbation of heart failure (1)Cardiovascular death or hospital admission for CHF (1)cancer related death (1)hypertension (1)Serious adverse event (1) Options Numeric bar chart forest plot medians
Trial	Studied trt	Control trt	patients	tags	ROB	Trial result	All cause death	Major bleeding